GenoSensor Corporation is a genomic technology company, aiming to improve human healthcare by developing and marketing products and services for genomic research, drug discovery, predisposition gene screening, therapeutic assessment and other bioscience applications.
The Analysis You can Trust
GenoSensor’s focus is to provide products and services to customers who conduct genomic research and/or are in needs of genomic solutions in all life sciences. The company also develops assays for specific applications.
By means of integrating high-throughput laboratory and microarray fabrication facilities, GenoSensor has become a nationwide leading company in bioassay services and development. Currently, company’s genetic products and services are helping laboratories worldwide for their sample processing, nucleic acid preparation, genetic profiling and gene screening. Full services including sample-in and data-out genomic experimentations are provided for the applications of gene expression profiling, genotyping, sequencing and other genomic research. The production pipelines are robust and highly reproducible. The service is reliable, cost-effective, and fast turnaround. Meeting the needs of individual customers is company’s key goal.
Assay 3 target genes unique to SARS-CoV-2 having higher specificity and exhibiting lower risk for mutation.
Targeted specificity to 100% of currently available complete genomes for SARS-CoV-2.
Ready to use all-in-one master mix reagents and controls minimize variability.